C2Dx, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

C2Dx, Inc. - overview

Established

2019

Location

Kalamazoo, MI, US

Primary Industry

Medical Devices & Equipment

About

Based in Michigan, US, and founded in 2019 by its CEO, Kevin McLeod, C2Dx, Inc. , operates as a manufacturing company that offers medical devices. C2Dx is committed to providing leading medical products and superior customer service while continually evolving to ensure that healthcare providers have the devices and technology they need. In 2019, Plymouth Growth Partners formed C2Dx, Inc.


The company offers various medical devices that include the STIC Intra-Compartmental Pressure Monitor, used for the diagnosis of compartment syndrome, T/Pump® Localized Temperature Therapy System, used for localized warming and cooling therapy, and the Hemostatix Thermal Scalpel, used for various surgeries. The company also provides a clinical insights library for research and information related to diagnoses.


Current Investors

Straylight Capital

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment

Website

www.c2dx.com

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

C2Dx, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Secondary BuyoutCompletedC2Dx, Inc.-
Add-on, Corporate Carve OutCompletedCook Medical's Otolaryngology/Head and Neck Surgery Assets-
Add-onCompletedHemostatix Medical Technologies LLC-
Company FormationCompletedC2Dx, Inc.-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.